Ioana Preston, MD
PeerOksana A. Shlobin, MD
PeerEmerging PH Therapeutics: Ralinepag
Ioana Preston, MD
PeerImatinib for Group 1 PAH
Oksana A. Shlobin, MD
PeerCTD-PAH: What Is the Focus in 2023?
Dinesh Khanna, MD, MS
PeerUnderstanding the 4-Strata Approach to Risk Assessment (RA) for Patient Monitoring and Management
Vallerie V. McLaughlin, MD
PeerVallerie V. McLaughlin, MD
PeerRichard Krasuski, MD
PeerSudarshan Rajagopal, MD, PhD
Peer